Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.0018
-0.0001 (-5.26%)
Feb 12, 2026, 1:23 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €906 as of February 12, 2026. Its market cap has decreased by -98.88% in one year.
Market Cap
906.00
Enterprise Value
133.06K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since November 5, 2024, Neovacs's market cap has decreased from 296.00K to 906.00, a decrease of -99.69%. That is a compound annual growth rate of -98.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 906.00 | -78.15% |
| Dec 31, 2025 | 4.15K | -97.26% |
| Dec 31, 2024 | 151.14K | -48.94% |
| Nov 5, 2024 | 296.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 17.82M |
| Poxel | 15.69M |
| NFL Biosciences | 14.93M |
| Oncodesign Precision Medicine Société anonyme | 10.11M |
| Plant Advanced Technologies | 9.42M |
| TME Pharma | 7.66M |
| Aton | 5.13M |
| Quantum Genomics Société Anonyme | 5.03M |